Asst. Prof. LOKMAN HEKİM TANRIVERDİ

Metrics

Publication

Publication (WoS)

Publication (Scopus)

Citation (WoS)

226

H-Index (WoS)

Citation (Scopus)

264

H-Index (Scopus)

Citation (Scholar)

349

H-Index (Scholar)

Citation (Sobiad)

H-Index (Sobiad)

Citation (Sum Other)

Project

Open Access

UN Sustainable Development Goals

Education

2018 - 2021

Doctorate

Inonu University, Sağlık Bilimleri Enstitüsü, Medical Pharmacology, Turkey

2014 - 2016

Undergraduate

Inonu University, Tıp Fakültesi, Turkey

Foreign Languages

C2 Mastery

English

Certificates, Courses and Trainings

2022

Biomedical Research - Basic/Refresher

Health&Medicine

The Collaborative Institutional Training Initiative

2022

Hot Topics

Health&Medicine

The Collaborative Institutional Training Initiative

2022

Good Clinical Practice Course (US FDA focus)

Health&Medicine

The Collaborative Institutional Training Initiative

2022

Research Study Design (RSD)

Health&Medicine

The Collaborative Institutional Training Initiative

2022

GCP for Clinical Trials with Investigational Drugs and Biologics (ICH Focus)

Health&Medicine

The Collaborative Institutional Training Initiative

2022

Biomedical Sciences

Health&Medicine

The Collaborative Institutional Training Initiative

2022

CIRTification: Community Involvement in Research Training

Health&Medicine

University of Illinois at Chicago

2022

Eğiticinin Eğitimi Sertifikası

Health&Medicine

Selçuk Üniversitesi

2021

Klinik Çalışmalarda Adaptif Tasarımlar

Health&Medicine

Clinical Research Association

2021

İleri İyi Klinik Uygulamalar

Health&Medicine

Clinical Research Association

2021

Temel İyi Klinik Uygulamalar

Health&Medicine

Clinical Research Association

2016

Meta-analysis: Concepts and Applications

Health&Medicine

Biostat Inc.

2016

HIPAA Security Training

Health&Medicine

Yale University

2016

HIPAA for Research Staff

Health&Medicine

Yale University

2016

HIPAA for Clinical Care Providers

Health&Medicine

Yale University

2013

Biological Safety Training Level II

Health&Medicine

Yale University

2013

Biological Safety Training Level I

Health&Medicine

Yale University

2013

Human Subject Protection Training

Health&Medicine

Yale University

Research Areas

Medicine

Internal Medicine Sciences

Pharmacology

Research Areas Based on Academic Activities

Avesis Research Areas

WoS Research Areas

Scopus Research Areas

Academic Positions

2022 - Present

Assistant Professor

Inonu University, Tıp Fakültesi, Dahili Tıp Bilimleri

2024 - 2024

Assistant Professor

Escuela de Medicina, Unidad de Farmacología

2022 - 2023

Researcher

Yale University, Yale-New Haven Hospital

Managerial Experience

2024 - Present

Assistant Director of the Institute

Inonu University, Sağlık Bilimleri Enstitüsü

2024 - Present

Applied Research Center Board Member

Inonu University

2023 - Present

Member of the Commission

Inonu University, Tıp Fakültesi

2022 - Present

Member of the Commission

Inonu University, Tıp Fakültesi

2022 - Present

Dönem II Koordinatör Yardımcısı

Inonu University, Tıp Fakültesi, Dahili Tıp Bilimleri

2022 - Present

USMLE Koordinatör Yardımcısı

Inonu University, Tıp Fakültesi, Dahili Tıp Bilimleri

Non Academic Experience

2022 - Present

Researcher

Yale-New Haven Hospital, Yale University, Researcher

2016 - 2016

Postgraduate Fellow

Yale-New Haven Hospital, Yale University School of Medicine, Postgraduate Fellow

2013 - 2013

Research Associate

Aortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, Research Associate

Articles

2025

1. Effectiveness and Safety of Antibiotics in Kidney Transplant Recipients With Asymptomatic Bacteriuria: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Aslan A. T., Tanriverdi L. H., Hernandez A. V., Akova U., Kutluca K., Chan S., et al.

Open Forum Infectious Diseases , vol.12, no.9, 2025 (SCI-Expanded, Scopus)

2025

2. S1P Receptor Modulators Improve Clinical Outcomes in Ulcerative Colitis

Tanriverdi L. H., Aksan F., Aroniadis O., Monzur F.

JOURNAL OF CLINICAL GASTROENTEROLOGY , vol.1, no.No information, pp.1-12, 2025 (SCI-Expanded, Scopus)

2025

3. Alamandine: Protective Effects Against Renal Ischemia-Reperfusion Injury-Induced Renal and Liver Damage in Diabetic Rats.

Cengiz A. N., Özhan O., Tanriverdi L. H., Dogru F., Yildiz A., Polat A., et al.

Journal of biochemical and molecular toxicology , vol.39, no.8, 2025 (SCI-Expanded, Scopus)

2025

4. EFFICACY OF ROXADUSTAT IN CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS WITH ANEMIA: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

TANRIVERDİ L. H., UYSAL A., AKYAY A., ÖNCÜL Y., SARICI A.

Hematology, Transfusion and Cell Therapy , vol.47, pp.5-6, 2025 (ESCI, Scopus)

2025

5. Efficacy of beta-blocker agents on clinical outcomes in patients with thoracic aortic aneurysm: A systematic review and meta-analysis of randomized controlled trials

Tanriverdi L. H., Barrett A., Kalyanasundaram A., Zafar M. A., Ziganshin B. A., Elefteriades J. A.

VASCULAR PHARMACOLOGY , vol.159, no.107494, pp.1-8, 2025 (SCI-Expanded, Scopus)

2025

6. Efficacy, Safety, and Tolerability of Ferric Carboxymaltose and Iron Sucrose in Iron-Deficiency Anemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Tanriverdi L. H., SARICI A.

Turkish Journal of Hematology , vol.42, no.2, pp.119-135, 2025 (SCI-Expanded, Scopus, TRDizin)

2025

7. Safety Profile of Roxadustat in Anemic Patients: A Meta-Analysis of 21 RCTs

TANRIVERDİ L. H., SARICI A., ERKURT M. A., BERKTAŞ H. B.

Medeniyet medical journal , vol.40, pp.250-261, 2025 (ESCI, Scopus, TRDizin)

2025

8. Glucagon-like peptide-1 receptor agonists associated with improved clinical outcomes in patients with inflammatory bowel disease: a retrospective cohort study

Aksan F., Abboud A., TANRIVERDİ L. H., Aroniadis O. C., Monzur F.

Naunyn-Schmiedeberg's Archives of Pharmacology , 2025 (SCI-Expanded, Scopus)

2024

9. SHIFTING PARADIGMS: EXPLORING ENARODUSTAT FOR ANEMIA IN CHRONIC KIDNEY DISEASE IN A META ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Tanrıverdi L. H., Sarıcı A.

Hematology, Transfusion and Cell Therapy , vol.46, no.3, pp.6-7, 2024 (ESCI, Scopus)

2024

10. Efficacy and safety of molidustat for the anemia of chronic kidney disease: A systematic review and meta-analysis of randomized controlled trials

Tanrıverdi L. H., Tay M., Sarıcı A.

Annals of Medical Research , vol.31, no.2, pp.177-184, 2024 (TRDizin)

2023

11. The Experience of Ibrutinib in Chronic Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience

Sarıcı A., Erkurt M. A., Kuku İ., Kaya E., Berber İ., Biçim S., et al.

İstanbul Medical Journal , vol.24, no.2, pp.216-220, 2023 (TRDizin)

2023

12. The impact of smartphone applications on bowel preparation, compliance with appointments, cost-effectiveness, and patients' quality of life for the colonoscopy process: A scoping review.

Aksan F., Tanriverdi L. H., Figueredo C. J., Barrera L. C., Hasham A., Jariwala S. P.

Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association , vol.29, no.2, pp.71-87, 2023 (SCI-Expanded, Scopus)

2023

13. Novel aspects of the renin-angiotensin system for pulmonary arterial hypertension.

Tanriverdi L. H.

Hypertension research : official journal of the Japanese Society of Hypertension , vol.46, pp.1049-1050, 2023 (SCI-Expanded, Scopus)

2023

14. The Beneficial Effects of Ivabradine Aganist Myocardial Damage induced by Isoproterenol in Rats

POLAT S., ALTUNTAŞ M., GÜNATA M., POLAT A., TANRIVERDİ L. H., YILDIZ A., et al.

Medicine Science , 2023 (TRDizin)

2022

15. Thalidomide Reduces Cortical And Thalamic Neuronal Degeneration In A Rat Model Of Parkinson’s Disease

Polat S., Erşan E., Günata M., Durak M. A., Tanrıverdi L. H., Yıldız A., et al.

Annals of Medical Research , vol.29, no.S1, pp.47-48, 2022 (TRDizin)

2022

16. Activation of the Mas receptors by AVE0991 and MrgD receptor using Alamandine to limit the deleterious effects of Ang II‐induced hypertension

Tanriverdi L. H., Özhan O., Ulu A., Yildiz A., Ateş B., Vardi N., et al.

FUNDAMENTAL AND CLINICAL PHARMACOLOGY , vol.1, no. 1, pp.1-15, 2022 (SCI-Expanded, Scopus)

2022

17. Dose-dependent subacute cardiovascular effects of modafinil in rats

Canyurt D., Tanriverdi L. H., Ozhan O., Cansel M., Parlakpinar H., Vardi N., et al.

DRUG AND CHEMICAL TOXICOLOGY , vol.45, no.3, pp.1044-1053, 2022 (SCI-Expanded, Scopus)

2021

18. Efficacy and safety of ruxolitinib plus extracorporeal photopheresis in acute and chronic graft versus host disease: A single center experience

Sarıcı A., Erkurt M. A., Bahçecioğlu Ö. F., Tanriverdi L. H., Berber İ., Kaya E., et al.

Annals of Medical Research , vol.28, no.11, pp.2065-2070, 2021 (TRDizin)

2021

19. Protective effects of naringin on valproic acid-induced hepatotoxicity in rats

Koroglu O. F., Gunata M., Vardi N., Yildiz A., Ates B., Colak C., et al.

TISSUE & CELL , vol.72, 2021 (SCI-Expanded, Scopus)

2021

20. The efficacy of voxelotor, 900 mg in patients with sickle cell anaemia: A meta-analysis of the randomised controlled trials

Tanriverdi L. H., Sarici A., Erkurt M. A., Parlakpinar H.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75, no.6, 2021 (SCI-Expanded, Scopus)

2021

21. Systemic Sodium Hydrosulfide Causes Neuronal Degeneration in a Dose-Dependent Manner in Cerebrum but not Through the Oxidative Stress Pathway: An Experimental Study

Tanriverdi L. H., ÖZHAN O., PARLAKPINAR H., DURAK M. A., YILDIZ A., VARDI N., et al.

NEUROENDOCRINOLOGY , vol.111, no.SUPPL 1, pp.24-25, 2021 (SCI-Expanded, Scopus)

2021

22. Comparison of the renal response of bortezomib-based induction and conventional regimen in multiple myeloma patients with renal failure

SARICI A., KAYA E., ERKURT M. A., BERBER İ., TANRİVERDİ L. H., bahçecioğlu ö. f., et al.

Annals of Medical Research , vol.28, no.10, pp.1824-1829, 2021 (TRDizin)

2019

23. Acute and Subacute Effects of Low Versus High Doses of Standardized Panax ginseng Extract on the Heart: An Experimental Study

PARLAKPINAR H., ÖZHAN O., ERMİŞ N., VARDI N., ÇİĞREMİŞ Y., TANRIVERDI L. H., et al.

CARDIOVASCULAR TOXICOLOGY , vol.19, no.4, pp.306-320, 2019 (SCI-Expanded, Scopus)

2019

24. A Current Medical Term: Nocebo

TANRIVERDİ L. H., PARLAKPINAR H.

Journal of Traditional Medical Complementary Therapies , vol.2, 2019 (TRDizin)

2018

25. Protective and therapeutic effects of dexpanthenol on isoproterenol-induced cardiac damage in rats.

Kalkan F., PARLAKPINAR H., DİŞLİ O. M., Tanriverdi L. H., ÖZHAN O., Polat A., et al.

Journal of cellular biochemistry , vol.119, no.9, pp.7479-7489, 2018 (SCI-Expanded, Scopus)

2017

26. Inhibition of NADPH oxidase by apocynin promotes myocardial antioxidant response and prevents isoproterenol-induced myocardial oxidative stress in rats

TANRIVERDI L. H., PARLAKPINAR H., ÖZHAN O., ERMİŞ N., POLAT A., VARDI N., et al.

FREE RADICAL RESEARCH , vol.51, no.9-10, pp.772-786, 2017 (SCI-Expanded, Scopus)

2016

27. A patient with primary hyperoxaluria who developed excessive pericardial effusiondespite intensive dialysis

Gürel A., Pembegül Yiğit İ., Taşkapan H., Şamdancı E., Tanriverdi L. H.

Medicine Science , vol.3, 2016 (TRDizin)

2016

28. WHOLE EXOME SEQUENCE FOR THORACIC AORTIC ANEURYSMS

Ziganshin B. A., Bailey A. E., Coons C., Dykas D., Charilaou P., Tanriverdi L. H., et al.

CARDIOLOGY , vol.134, pp.177, 2016 (SCI-Expanded, Scopus)

2016

29. A patient with Primary Hyperoxaluria who developed excessive pericardial effusion despite intensive dialysis

GÜREL A., Yiğit İ. P., TAŞKAPAN H., ŞAMDANCI E., TANRIVERDİ L. H.

Medicine Science , vol.5, 2016 (TRDizin)

2015

30. Routine Genetic Testing for Thoracic Aortic Aneurysm and Dissection in a Clinical Setting

Ziganshin B. A., Bailey A. E., Coons C., Dykas D., Charilaou P., Tanriverdi L. H., et al.

ANNALS OF THORACIC SURGERY , vol.100, no.5, pp.1604-1612, 2015 (SCI-Expanded, Scopus)

Papers Presented at Peer-Reviewed Scientific Conferences

2025

1. Investigation of the Therapeutic Effects of α-Lipoic Acid and Ambrisentan in a Monocrotaline-Induced Pulmonary Arterial Hypertension Model in Rats

Ayık S., Hüz M., Ulutaş Z., Balkar M. E., Tanbek K., Sönmez R., et al.

3rd INTERNATIONAL AND 28th NATIONAL PHARMACOLOGY CONGRESS, Antalya, Turkey, 20 - 23 November 2025, (Summary Text)

2025

2. EFFICACY OF ROXADUSTAT IN CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS WITH ANEMIA: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

TANRIVERDİ L. H., UYSAL A., AKYAY A., ÖNCÜL Y., SARICI A.

EHOC 2025, İstanbul, Turkey, 18 - 20 May 2025, (Summary Text)

2024

3. Abstract 4147504: Efficacy and Safety of Vorapaxar in Patients with Peripheral Arterial Disease: A Meta-Analysis of Randomized Controlled Trials

Doğan M. M., TANRIVERDİ L. H.

American Heart Association's 2024 Scientific Sessions, Turkey, 17 November 2024, vol.150, (Summary Text)

2024

4. Abstract 4136604: Efficacy of angiotensin receptor blockers in thoracic aortic aneurysm: meta-analysis of randomized controlled trials

TANRIVERDİ L. H., Doğan M. M., Barrett A., Zafar M. A., Ziganshin B. A., Elefteriades J. A.

American Heart Association's 2024 Scientific Sessions, Turkey, 16 November 2024, vol.150, (Summary Text)

2024

5. Abstract 4136758: Apabetalone: evaluating cardiovascular and safety outcomes in meta-analysis

TANRIVERDİ L. H., Doğan M. M., Bytyci I., Penson P., Toth P., Banach M.

American Heart Association's 2024 Scientific Sessions, Turkey, 16 November 2024, vol.150, (Summary Text)

2024

6. S1092 Continuing or Discontinuing Mesalamine in Crohn’s Disease? A Multinational, Propensity-Matched, Retrospective Cohort Study

AKSAN F., TANRIVERDİ L. H., Aroniadis O. C.

American College of Gastroenterology 2024 Annual Scientific Meeting, Turkey, 25 - 30 October 2024, vol.119, pp.773-774, (Summary Text)

2024

7. S743 Sex-specific Response Patterns to Tricyclic Antidepressants in Patients With Diarrhea-Predominant Irritable Bowel Syndrome: A Propensity-Matched, Retrospective Cohort Study

AKSAN F., TANRIVERDİ L. H., Aroniadis O. C.

ACG's Annual Scientific Meeting and Postgraduate Course, United States Of America, 26 October 2024, vol.119, pp.511-512, (Summary Text)

2024

8. CLL-247 Venetoclax Plus Ibrutinib As First-line Treatment in Patients With Chronic Lymphocytic Leukemia: Meta-Analysis of Randomised Controlled Trials

TANRIVERDİ L. H., SARICI A.

Society of Hematologic Oncology 2024 Annual Meeting, Texas, United States Of America, 4 - 07 September 2024, vol.24, pp.349, (Summary Text)

2024

9. VADADUSTAT VS. DARBEPOETIN IN ANEMIC CHRONIC KIDNEY DISEASE: ANALYZING EFFICACY, SAFETY, AND TOLERABILITY VIA META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Sarıcı A., Doğan M. M., Tanrıverdi L. H.

European Hematology Association Hybrid Congress, Madrid, Spain, 13 - 16 June 2024, vol.25729241, no.1567, pp.2899, (Summary Text)

2023

10. FERRİK DERİSOMALTOZ'UN DEMİR SÜKROZ İLE KARŞILAŞTIRILDIĞINDA DEMİR EKSİKLİĞİ ANEMİSİ OLAN HASTALARDA ETKİLİLİĞİ VE GÜVENİLİRLİĞİ: RANDOMİZE KONTROLLÜ ÇALIŞMALARIN SİSTEMATİK DERLEMESİ VE META-ANALİZİ

Tanriverdi L. H., Sarici A., Aksan F., Hernandez A. V.

27. Ulusal, 2. Uluslararası Farmakoloji Kongresi, Antalya, Turkey, 23 - 26 November 2023, pp.249-250, (Summary Text)

2023

11. DEMİR EKSİKLİĞİ ANEMİSİNDE FERRİK KARBOKSİMALTOZ VE DEMİR SÜKROZUN ETKİLİLİĞİ: RANDOMİZE KONTROLLÜ ÇALIŞMALARIN SİSTEMATİK DERLEMESİ VE META-ANALİZİ

Tanriverdi L. H., Sarici A.

27. Ulusal, 2. Uluslararası Farmakoloji Kongresi, Antalya, Turkey, 23 - 26 November 2023, pp.257-258, (Summary Text)

2023

12. RENİN-ANJİYOTENSİN SİSTEM İLİŞKİLİ İLAÇLARIN KAN BASINCI ÜZERİNE KRONOFARMAKOLOJİK ETKİLERİ: RANDOMİZE KONTROLLÜ ÇALIŞMALARIN SİSTEMATİK DERLEMESİ

Yildiz E. Z., Özcan M. A., Gündüz I. N., Doğan Z., Özen M., Uğur H. S., et al.

27. Ulusal, 2. Uluslararası Farmakoloji Kongresi, Antalya, Turkey, 23 November 2023, pp.299-300, (Summary Text)

2023

13. S974 Efficacy and Safety of Adalimumab in Inducing Clinical Remission in Crohns Disease: A Meta-Analysis With Subgroup Analysis

Aksan F., Tanrıverdi L. H., Monzur F.

2023 ACG Annual Meeting, Vancouver, Canada, 23 - 26 October 2023, vol.118, pp.735-736, (Summary Text)

2023

14. S975 Ozanimod for Induction and Maintenance of Remission in Ulcerative Colitis: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Aksan F., Tanrıverdi L. H., Monzur F.

ACG's 2023 Annual Scientific Meeting, Vancouver, Canada, 20 - 25 October 2023, vol.118, pp.735-736, (Summary Text)

2023

15. MPN-139 Is Ferric Carboxymaltose a Safer Option Compared to Iron Sucrose?

Sarıcı A., Tanrıverdi L. H.

Society of Hematologic Oncology 2023 Annual Meeting, Texas, United States Of America, 6 - 09 September 2023, vol.23, pp.384, (Summary Text)

2023

16. Demir Eksikliği Anemisi Hastalığında Desidustat'ın Etkililiği ve Güvenirliğinin Araştırılması: Randomize Kontrollü Çalışmaların Sistematik Derlemesi ve Meta Analizi

TANRIVERDİ L. H., SARICI A.

13th International Medicine and Heath Sciences Researches Congress, Turkey, 26 - 27 August 2023, pp.349-350, (Summary Text)

2022

17. The Impact of Smartphone Applications on Bowel Preparation, Compliance With Appointments, Cost-Effectiveness and Patients’ Quality of Life for the Colonoscopy Process: A Scoping Review

Aksan F., Tanriverdi L. H., Figueredo C. J., Hasham A., Jariwala S. P.

AMERICAN COLLEGE OF GASTROENTEROLOGY ANNUAL SCIENTIFIC MEETING 2022, Louisiana, United States Of America, 25 October 2022, pp.338, (Summary Text)

2022

18. TALİDOMİD PARKİNSON HASTALIĞI SIÇAN MODELİNDE KORTİKAL VE TALAMİK NÖRONAL DEJENERASYONU AZALTIR

Polat S., erşan e., günata m., DURAK M. A., TANRIVERDİ L. H., YILDIZ A., et al.

Uluslararası Maldia Sağlık Bilimleri Kongresi, Malatya, Turkey, 14 October 2022, (Summary Text)

2022

19. Talidomid Parkinson Hastalığı Sıçan Modelinde Kortikal ve Talamik Nöronal Dejenersayon Azaltır

POLAT S., ERŞAN E., GÜNATA M., DURAK M. A., TANRIVERDİ L. H., YILDIZ A., et al.

Uluslararası Maldia Sağlık Bilimleri Kongresi, Malatya, Turkey, 14 - 16 October 2022, (Summary Text)

2021

20. ALAMANDINE, AN MRGD RECEPTOR AGONIST PROVIDES ADDITIONAL ANTIHYPERTENSIVE AND THERAPEUTIC EFFECTS TO AVE0991, A MAS RECEPTOR AGONIST IN AN ANGIOTENSIN II-INDUCED HYPERTENSION MODEL

TANRİVERDİ L. H., ÖZHAN O., ULU A., YILDIZ A., ATEŞ B., VARDI N., et al.

1. Uluslararası Farmakoloji Kongresi, Turkey, 04 November 2021, (Summary Text)

2021

21. INVESTIGATION OF THE EFFECTS OF AGOMELATINE IN THE MODEL OF CISPLATIN-INDUCED AUTOTOXICITY

PARMAKSIZ T., POLAT S., VARAN E., TOPLU Y., GÜNATA M., TANRİVERDİ L. H., et al.

1. Uluslararası Farmakoloji Kongresi, Turkey, 04 November 2021, (Summary Text)

2021

22. Effects of fondaparinux against doxorubicin-induced cardiotoxicity in rats

Su B., Günata M., TANRIVERDİ L. H., ÇOLAK M. C., VARDI N., ÇİĞREMİŞ Y., et al.

28nd International Student Congress of (bio)Medical Sciences (ISCOMS), June 8-10, 2021, Groningen, The Netherlands., Groningen, Netherlands, 8 - 10 June 2021, (Summary Text)

2021

23. The protective and therapeutic effect of ranolazine on cisplatin-induced renal damage in rats.

Göncü H., TANRIVERDİ L. H., Günata M., BEYTUR A., VARDI N., ÇİĞREMİŞ Y., et al.

28nd International Student Congress of (bio)Medical Sciences (ISCOMS), June 8-10, 2021, Groningen, The Netherlands, Groningen, Netherlands, 08 June 2021, (Summary Text)

2021

24. Protective and therapeutic effects of ranolazine on methotrexate induced liver damage in rats.

Polat M. E., Sarı E., TANRIVERDİ L. H., Günata M., ALADAĞ M., ŞAHİN A. F., et al.

28nd International Student Congress of (bio)Medical Sciences (ISCOMS), June 8-10, 2021, Groningen, The Netherlands, Groningen, Netherlands, 08 June 2021, (Summary Text)

2020

25. Systemic Sodium Hydrosulfide Causes Neuronal Degeneration in a Dose-Dependent Manner in Cerebrum but not through the Oxidative Stress Pathway: An Experimental Study

TANRİVERDİ L. H., ÖZHAN O., PARLAKPINAR H., DURAK M. A., YILDIZ A., VARDI N., et al.

4th International Congress of the Turkish Neuroendocrinology Society, İstanbul, Turkey, 26 November 2020, (Summary Text)

2019

26. Modafinilin sıçanlarda doz bağımlı subakut kardiyovasküler tesirleri

Tanrıverdi L. H., Canyurt D., ÖZHAN O., CANSEL M., PARLAKPINAR H., VARDI N., et al.

25. Ulusal Farmakoloji Kongresi, İzmir, Turkey, 4 - 07 November 2019, (Summary Text)

2019

27. Hemoglobin S Polimerizasyon İnhibitörü Voxelotor’un Orak Hücre Hastalığındaki Etkililiği ve Güvenliliği: Randomize Kontrollü Çalışmaların Sistematik Derlemesi ve Meta-Analizi

TANRIVERDİ L. H., SARICI A., PARLAKPINAR H., ERKURT M. A.

25. Ulusal Farmakoloji Kongresi, İzmir, Turkey, 04 November 2019, (Summary Text)

2019

28. TANI ANINDA BÖBREK YETMEZLİĞİ OLAN MULTİPL MYELOM HASTALARININ TEDAVİ SONRASI BÖBREK FONKSİYONLARININ DEĞİŞİMİ

SARICI A., KAYA E., ERKURT M. A., TANRIVERDİ L. H., BERBER İ., BAHÇECİOĞLU Ö. F., et al.

45. Ulusal Hematoloji Kongresi, Antalya, Turkey, 30 October - 02 November 2019, pp.219, (Summary Text)

2018

29. Does thalidomide have beneficial or harmfull effects on cisplatin-induced cardiotoxicity in rats?.

Tosun N. S., TANRIVERDİ L. H., ÖZHAN O., VARDI N., PARLAKPINAR H., YILDIZ A., et al.

1. Uluslararası Battalgazi Multidisipliner Çalışmalar Kongresi, 7-9 Aralık 2018, Malatya, Türkiye., Malatya, Turkey, 7 - 09 December 2018, pp.719-735, (Full Text)

2018

30. SIÇANLARDA EMBELİN’İN RENAL İSKEMİ VE REPERFÜZYONHASARINDA KORUYUCU VE TEDAVİ EDİCİ ETKİLERİNİNARAŞTIRILMASI

PARLAKPINAR H., başdaş f., ÖZHAN O., tanrıverdi h., BEYTUR A., yıldız a., et al.

Iğdır 1. Uluslararası Multi Disipliner Çalışmalar Kongresi, 6 - 07 November 2018, (Full Text)

2018

31. Protective and therapeutic effects of embelin on renal ischemia-reperfusion injury in rats

PARLAKPINAR H., Başdaş F., ÖZHAN O., TANRIVERDİ L. H., BEYTUR A., YILDIZ A., et al.

1st International Iğdır Congress On Multidisciplinary Studies, Iğdır, Turkey, 6 December - 07 July 2018, vol.2, (Full Text)

2016

32. Frequency Distribution of Genetic Aberrations in Thoracic Aortic Disease

Ziganshin B. A., Bailey A. E., Coons C., Dykas D., Charilaou P., TANRIVERDİ L. H., et al.

AATS Aortic Symposium 2016, New York, United States Of America, 12 - 13 May 2016, (Summary Text)

2016

33. Whole Exome Sequence for Thoracic Aortic Aneurysms

Ziganshin B. A., Bailey A. E., Coons C., Dykas D., Charilaou P., TANRIVERDİ L. H., et al.

21st World Congress on Heart Disease, International Academy of Cardiology Annual Scientific Sessions 2016, United States Of America, 30 July - 01 August 2016, (Summary Text)

2015

34. Apocynin Promotes Myocardial Antioxidant Response And Prevents Isoproterenol-Induced Myocardial Oxidative Stress in rats

TANRIVERDİ L. H., PARLAKPINAR H., POLAT A., VARDI N., TANBEK K., YILDIZ A., et al.

22nd International Student Congress of (bio)Medical Sciences (ISCOMS), Groningen, Netherlands, 2 - 05 June 2015, (Summary Text)

2015

35. Routine Genetic Testing for Thoracic Aortic Aneurysm in a Clinical Setting

Ziganshin B. A., Bailey A. E., Coons C., Dykas D., TANRIVERDİ L. H., Tranquilli M., et al.

STS 51st Annual Meeting and STS/AATS Tech-Con 2015, California, United States Of America, 24 - 28 January 2015, (Summary Text)

2014

36. Protective and therapeutic effects of dexpanthenol on isoproterenol-induced cardiac damage in rats

KALKAN F., DİŞLİ O. M., PARLAKPINAR H., TANRIVERDİ L. H., POLAT A., TAŞLIDERE A., et al.

16. Ulusal Anatomi Kongresi, Malatya, Turkey, 11 - 14 September 2014, (Summary Text)

2014

37. Comprehensive Genetic Screening for Thoracic Aortic Aneurysm via Whole Exome Sequencing

Ziganshin B. A., Bailey A. E., Coons C., Dykas D., TANRIVERDİ L. H., Tranquilli M., et al.

; Comprehensive Genetic Screening for Thoracic Aortic Aneurysm via Whole Exome Sequencing; GenTAC Third Aortic Disease Summit, Baltimore, United States Of America, 13 July 2014, (Summary Text)

Books

2025

1. Kalsiyum Metabolizmasını Etkileyen İlaçlar, PTH ve D Vitamini

TANRIVERDİ L. H.

in: Temelden Kliniğe Hareket Sistemi, YAKINCI MEHMET CENGİZ, ÖZGÖR BİLGE, YOLBAŞ SERVET, Editor, Nobel Tıp Kitabevleri, pp.166-171, 2025

2025

2. Koku Duyusu Farmakolojisi

TANRIVERDİ L. H.

in: Temelden Kliniğe Duyu Sistemi, YAKINCI MEHMET CENGİZ, VARDI NİGAR, ÖZTÜRK LEVENT, Editor, Nobel Tıp Kitabevleri, İstanbul, pp.274-276, 2025

2024

3. Temelden Kliniğe Kardiyovasküler Sistem

YAKINCI M. C., TANRIVERDİ L. H., ÖZEKE Ö.

Nobel Tıp Kitabevleri, 2024

2024

4. Obstetri ve Jinekolojide Kullanılan Hipotalamus ve Hipofiz Hormonları

TANRIVERDİ L. H.

in: Temelden Kliniğe Kadın Genital Sistem, YAKINCI MEHMET CENGİZ, VARDI NİGAR, MELEKOĞLU RAUF, Editor, Nobel Tıp Kitabevleri, pp.234-240, 2024

2024

5. Anılarla Ahmet Kızılay

TANRIVERDİ L. H.

in: Anılarla Tıpta Öncüler-I, YAKINCI MEHMET CENGİZ, DURMAZ YAŞAR, ERKURT MEHMET ALİ, ALTUNTAŞ FEVZİ, Editor, Akademisyen Kitabevi, pp.733-740, 2024

2024

6. Gebelik ve Laktasyonda İlaç Kullanımı Prensipleri

TANRIVERDİ L. H.

in: Temelden Kliniğe Kadın Genital Sistem, YAKINCI MEHMET CENGİZ, VARDI NİGAR, MELEKOĞLU RAUF, Editor, Nobel Tıp Kitabevleri, pp.241-245, 2024

2023

7. Hekimlikte Acil ve Temel Uygulamalar Rehberi

YAKINCI M. C., BALKAN Z., NAÇAR M., TANRIVERDİ L. H.

Nobel Tıp Kitabevleri, İstanbul, 2023

2023

8. Temelden Kliniğe Sinir Sistemi

YAKINCI M. C., TANRIVERDİ L. H.

Nobel Tıp Kitabevleri, İstanbul, 2023

2023

9. Temelden Kliniğe Kardiyovasküler Sistem

YAKINCI M. C., TANRIVERDİ L. H.

Nobel Tıp Kitabevleri, İstanbul, 2023

2023

10. Tıp Dalları Tarihçesi

YAKINCI M. C., TANRIVERDİ L. H., ERKURT M. A., ALTUNTAŞ F., YİĞENOĞLU T. N.

Nobel Tıp Kitabevleri, İstanbul, 2023

2023

11. Genogram Çizme ve Mendeliyen Kalıtım Örnekleri

TANRIVERDİ L. H.

in: Hekimlikte Acil ve Temel Uygulamalar Rehberi, YAKINCI MEHMET CENGİZ, BALKAN ZEYNEP, NAÇAR MELİS, TANRIVERDİ LOKMAN HEKİM, Editor, Nobel Tıp Kitabevleri, İstanbul, pp.286-290, 2023

2023

12. FROM MEDICINAL MARVELS TO MISUSE OF AMPHETAMINES: A HISTORICAL JOURNEY

TANRIVERDİ L. H.

in: AMPHETAMINES: FROM DISCOVERY TO IMPACT, UYAR Emre, HASPOLAT Yusuf Kenan, Editor, Orient Publications, Ankara, pp.135-144, 2023

2022

13. Kısaltmalar-Tıbbi Kimyasal Element Simgeleri

TANRIVERDİ L. H.

in: Tıp Dili Rehberi, Dr. Cengiz Yakıncı, Dr. Başar Cander, Dr. Şeyma Fenercioğlu, Editor, Üsküdar Üniversitesi Yayınları, İstanbul, pp.44-46, 2022

2022

14. Soyağacında Kullanılan İmgeler

TANRIVERDİ L. H.

in: Tıp Dili Rehberi, Dr. Cengiz Yakıncı, Dr. Başar Cander, Dr. Şeyma Fenercioğlu, Editor, Üsküdar Üniversitesi Yayınları, İstanbul, pp.58-60, 2022

2021

15. Salgın

Tanriverdi L. H.

İnönü Üniversitesi Yayınevi, Malatya, 2021

2021

16. Drug use during pregnancy and lactation

TANRIVERDİ L. H.

in: ACET General Pharmacology, Acet HA, Parlakpinar H, Taşdemir S, Editor, İnönü Üniversitesi Yayınevi, pp.147-166, 2021

2018

17. Hava, Su ve Toprak

Tanriverdi L. H.

İnönü Üniversitesi Yayınevi, Malatya, 2018

Funded Projects

2022 - 2024

Demir eksikliği anemisi olan hastalarda ferrik derisomaltoz ve demir sükroz kullanımının etkililik ve güvenlilik profillerinin karşılaştırılması: Randomize kontrollü çalışmaların meta analizi

Project Supported by Higher Education Institutions , BAP Research Project

TANRIVERDİ L. H. (Executive), SARICI A., HERNANDEZ A. V., AKSAN F.

2020 - 2021

Investigation of the Effects of Alamandine and AVE0991 on Cardiac Remodeling, Vascular Proliferation, and Vascular Contraction-Relaxation Response in Angiotensin II-Induced Experimental Hypertension Model

Project Supported by Higher Education Institutions , BAP Research Project

(Project Abstract)

Tanrıverdi L. H., Parlakpınar H. (Executive), Vardı N., Acet H. A.

2013 - 2014

İsoproterenol ile olusturulmus kalp iskemi modelinde apocynin'in koruyucu ve tedavi edici etkisinin arastırılması

TUBITAK Project , 2209-A - Üniversite Öğrencileri Araştırma Projeleri Destekleme Programı

(Project Abstract)

Tanrıverdi L. H. (Executive), Parlakpınar H., Vardı N., Polat A.

Activities in Scientific Journals

2024 - Present

Annals of Medical Research

Assistant Editor/Section Editor

2024 - Present

CELL BIOCHEMISTRY AND FUNCTION

Committee Member

2022 - Present

Interventional Cardiology

Committee Member

Memberships and Roles in Scientific Organizations

2023 - Present

European Society of Clinical Microbiology and Infectious Diseases

Member

2020 - Present

Clinical Research Association

Member

2018 - Present

Turkish Pharmacological Society

Member

2020 - 2022

International Alliance of Clinical and Forensic Toxicologists - IACFT

Member

Peer Reviews in Scientific Publications

February 2026

FRONTIERS IN IMMUNOLOGY

Journal Indexed in SCI-E

February 2026

NAUNYN-SCHMIEDEBERG'S ARCHIVES OF PHARMACOLOGY

Journal Indexed in SCI-E

February 2026

FRONTIERS IN PHARMACOLOGY

Journal Indexed in SCI-E

February 2026

FRONTIERS IN PHARMACOLOGY

Journal Indexed in SCI-E

January 2026

FRONTIERS IN CARDIOVASCULAR MEDICINE

Journal Indexed in SCI-E

January 2026

FRONTIERS IN PHARMACOLOGY

Journal Indexed in SCI-E

December 2025

BMC CARDIOVASCULAR DISORDERS

Journal Indexed in SCI-E

September 2025

CELL BIOCHEMISTRY AND FUNCTION

Journal Indexed in SCI-E

August 2025

CLINICAL THERAPEUTICS THE INTERNATIONAL, PEER-REVIEWED JOURNAL OF DRUG THERAPY

Journal Indexed in SCI-E

August 2025

FRONTIERS IN CARDIOVASCULAR MEDICINE

Journal Indexed in SCI-E

August 2025

JOURNAL OF INFLAMMATION RESEARCH

Journal Indexed in SCI-E

August 2025

BMC CARDIOVASCULAR DISORDERS

Journal Indexed in SCI-E

June 2025

FRONTIERS IN PUBLIC HEALTH

Journal Indexed in SCI-E

June 2025

FRONTIERS IN PHARMACOLOGY

Journal Indexed in SCI-E

June 2025

JOURNAL OF EVIDENCE-BASED MEDICINE

Journal Indexed in SCI-E

June 2025

JOURNAL OF EVIDENCE-BASED MEDICINE

Journal Indexed in SCI-E

March 2025

BMC CARDIOVASCULAR DISORDERS

Journal Indexed in SCI-E

March 2025

SCIENTIFIC REPORTS

Journal Indexed in SCI-E

March 2025

JOURNAL OF INFLAMMATION RESEARCH

Journal Indexed in SCI-E

March 2025

CELL BIOCHEMISTRY AND FUNCTION

Journal Indexed in SCI-E

March 2025

FRONTIERS IN PUBLIC HEALTH

Journal Indexed in SCI-E

December 2024

CELL BIOCHEMISTRY AND FUNCTION

Journal Indexed in SCI-E

December 2024

FRONTIERS IN MEDICINE

Journal Indexed in SCI-E

December 2024

SCIENTIFIC REPORTS

Journal Indexed in SCI-E

November 2024

CELL BIOCHEMISTRY AND FUNCTION

Journal Indexed in SCI-E

April 2024

DRUG DESIGN, DEVELOPMENT AND THERAPY

Journal Indexed in SCI-E

January 2024

CELL BIOCHEMISTRY AND FUNCTION

Journal Indexed in SCI-E

December 2023

MDM Policy and Practice

Journal Indexed in ESCI

November 2023

JOURNAL OF PHARMACY AND PHARMACOLOGY

Journal Indexed in SCI-E

October 2023

JOURNAL OF PHARMACY AND PHARMACOLOGY

Journal Indexed in SCI-E

August 2023

NEUROTOXICITY RESEARCH

Journal Indexed in SCI-E

July 2023

NEUROTOXICITY RESEARCH

Journal Indexed in SCI-E

July 2023

CURRENT MOLECULAR MEDICINE

Journal Indexed in SCI-E

July 2023

FRONTIERS IN ENDOCRINOLOGY

Journal Indexed in SCI-E

July 2023

CURRENT VASCULAR PHARMACOLOGY

Journal Indexed in SCI-E

June 2023

HYPERTENSION RESEARCH

Journal Indexed in SCI-E

May 2023

CURRENT VASCULAR PHARMACOLOGY

Journal Indexed in SCI-E

May 2023

CURRENT MOLECULAR MEDICINE

Journal Indexed in SCI-E

April 2023

BMC CARDIOVASCULAR DISORDERS

Journal Indexed in SCI-E

March 2023

BRITISH MEDICAL JOURNAL

SCI Journal

January 2023

FRONTIERS IN AGING NEUROSCIENCE

Journal Indexed in SCI-E

November 2022

CURRENT MOLECULAR PHARMACOLOGY

Journal Indexed in SCI-E

November 2022

HYPERTENSION RESEARCH

Journal Indexed in SCI-E

August 2022

CHINESE JOURNAL OF NATURAL MEDICINES

Journal Indexed in SCI-E

August 2022

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY

Journal Indexed in SCI-E

August 2022

OCULAR IMMUNOLOGY AND INFLAMMATION

Journal Indexed in SCI-E

August 2022

JOURNAL OF PHARMACY AND PHARMACOLOGY

Journal Indexed in SCI-E

August 2022

HYPERTENSION RESEARCH

Journal Indexed in SCI-E

August 2022

JOURNAL OF DRUG TARGETING

Journal Indexed in SCI-E

July 2022

BIOMED RESEARCH INTERNATIONAL

Journal Indexed in SCI-E

July 2022

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Journal Indexed in SCI-E

July 2022

Journal of Nutrition and Metabolism

Journal Indexed in ESCI

May 2022

BRITISH MEDICAL JOURNAL

Journal Indexed in SCI-E

February 2022

BRITISH MEDICAL JOURNAL

Journal Indexed in SCI-E

January 2022

BMC CARDIOVASCULAR DISORDERS

Journal Indexed in SCI-E

December 2021

BMC MEDICAL RESEARCH METHODOLOGY

Journal Indexed in SCI-E

November 2021

BMC CARDIOVASCULAR DISORDERS

Journal Indexed in SCI-E

October 2021

BMC CARDIOVASCULAR DISORDERS

Journal Indexed in SCI-E

July 2021

BMC MEDICAL RESEARCH METHODOLOGY

Journal Indexed in SCI-E

June 2021

BMC CARDIOVASCULAR DISORDERS

Journal Indexed in SCI-E

July 2020

BRITISH MEDICAL JOURNAL

Journal Indexed in SCI-E

October 2019

BRITISH MEDICAL JOURNAL

Journal Indexed in SCI-E

Scientific Project Refereeing

July 2024

TUBITAK Project

1002 - Quick Support Program, Inonu University, Turkey

March 2024

Project Supported by Higher Education Institutions

BAP Research Project, Firat University, Turkey

Awards

November 2024

Paul Dudley White International Scholar Award

American Heart Association

Citations

Total Citations (WOS): 9

h-index (WOS): 2

Scientific Research / Working Group Memberships

2024 - Present

Cardiovascular Pharmacotherapy

https://www.escardio.org/Working-groups/Working-Group-on-Cardiovascular-Pharmacotherapy

European Society of Cardiology, France

2024 - Present

Klinik Farmakoloji Çalışma Grubu (Clinical Pharmacology Working Group)

https://www.tfd.org.tr/Content/kfcg-yurutme-kurulu-uyeleri

Turkish Pharmacological Society , Türkiye

2023 - Present